Urabe, S., Isomoto, H., Ishida, T., Maeda, K., Inamine, T., Kondo, S., . . . Tsukamoto, K. (2015). Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. Biomed Res Int.
Čikaški stil citiranjaUrabe, Shigetoshi, et al. "Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease." Biomed Res Int 2015.
MLA način citiranjaUrabe, Shigetoshi, et al. "Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease." Biomed Res Int 2015.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.